Abstract
Medicinal Chemistry
Title: Synthesis and Biological Activity of 3-(2, 8, 9-trioxa-aza-1-germatricyclo [3. 3. 3. 0] undecane-1-yl)-caffeic Acid
Volume: 5 Issue: 4
Author(s): Lianbao Ye, Yan Luo, Xuedong Peng, Yuping Zhou and Xiaomin Ou
Affiliation:
Keywords: Germanium, caffeic acid, germatrane, 3-(2, 8, 9-trioxa-aza-1-germatricyclo[3. 3. 3. 0]undecane-1-yl)- hydroxycinnamic acids, 3-(2, 8, 9-trioxa-aza-1-germatricyclo[3. 3. 3. 0] undecane-1-yl)-caffeic acid, U14 tumor-cell, antitumor activity, tumor inhibitory
Abstract: Full text available
Export Options
About this article
Cite this article as:
Ye Lianbao, Luo Yan, Peng Xuedong, Zhou Yuping and Ou Xiaomin, Synthesis and Biological Activity of 3-(2, 8, 9-trioxa-aza-1-germatricyclo [3. 3. 3. 0] undecane-1-yl)-caffeic Acid, Medicinal Chemistry 2009; 5 (4) . https://dx.doi.org/10.2174/157340609788681539
DOI https://dx.doi.org/10.2174/157340609788681539 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Neurovascular Unit: Focus on the Regulation of Arterial Smooth Muscle Cells
Current Neurovascular Research Static Cerebral Blood Flow Autoregulation in Humans
Current Hypertension Reviews Metabolic Effects of Renal Denervation
Current Clinical Pharmacology Exercise Rehabilitation for the Patient with Intermittent Claudication: A highly Effective yet Underutilized Treatment
Current Drug Targets - Cardiovascular & Hematological Disorders Neurocognitive Monitoring and Care During Pediatric Cardiopulmonary Bypass — Current and Future Directions
Current Cardiology Reviews Elevation of E-Selectin Concentrations may Correlate with Potential Endothelial Dysfunction in Individuals with Hypopituitarism During Therapy with Growth Hormone
Current Neurovascular Research Potential Role of Rho-Associated Protein Kinase Inhibitors for Glaucoma Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Restoring the Dysfunctional Endothelium
Current Pharmaceutical Design The IL23/Th17 Pathway as a Therapeutic Target in Chronic Inflammatory Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Topical Bimatoprost Insert for Primary Open-Angle Glaucoma and Ocular Hypertension Treatment - A Phase II Controlled Study
Current Drug Delivery Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Coronary Artery Disease and Endothelial Dysfunction: Novel Diagnostic and Therapeutic Approaches
Current Medicinal Chemistry Arterial Wall Structure and Dynamics in Type 2 Diabetes Mellitus Methodological Aspects and Pathophysiological Findings
Current Diabetes Reviews The Use of Nitric Oxide Synthase Inhibitors in Inflammatory Diseases: A Novel Class of Anti-Inflammatory Agents
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Clinical and Pre-clinical Applications of the Transcendental Meditation Program® in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults
Current Hypertension Reviews Non-Invasive Diagnostic Tools for Investigating Endothelial Dysfunction
Current Pharmaceutical Design Effect of Piperine, Quercetin, Polysorbate 80 on the Oral Bioavailability of Losartan in Male Wistar Rats
Pharmaceutical Nanotechnology What Characterizes Endothelial Dysfunction in Preeclampsia? -The Action of NO and the Production of Prostacyclin is Reduced, While EDHF is Preserved in Omental Resistance Arteries in Preeclamptic Women
Current Women`s Health Reviews Pathophysiology of Atherosclerosis: The Role of Inflammation
Current Pharmaceutical Design Capsule Endoscopy in Crohn’s Disease
Current Drug Targets